Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

TNON vs VEEA: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

VEEA Wins Head-to-Head Institutional Verdict (3–1 across 6 Pillars · 6–2 Matrix Metrics)

VEEA Overall Winner 6-Pillar Tally: TNON 1 – 3 VEEA (2 Tie) Matrix Metrics: TNON 2 – 6 VEEA

As of Nov 16, 2026, Veea Inc. (VEEA) is the stronger overall head-to-head candidate over Tenon Medical, Inc. (TNON) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 3–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). TNON carries a Unified Composite Score of 41.0/100 (SELL) at $1.33 (N/M Forward P/E, -228.0% operating margin), whereas VEEA carries 47.7/100 (HOLD) at $4.78 (N/M Forward P/E, -3873.7% operating margin).

  • Technical & Structure Timing Caution: TNON is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.7); meanwhile VEEA trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 53.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About TNON vs VEEA
TNON NASDAQ
Tenon Medical, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$1.33
-5.32% 1D
Market Cap $3.8M
TTM Revenue $5.3M
Forward P/E N/M
Beta / 30D Vol -1.54β · 106% Vol
Unified Composite Score
41.0 / 100 SELL
Tech 25.0 Fund 43.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -33.3%), weak momentum, RSI 28
RSI-14: 27.7 · SMA20: $1.96 · SMA50: $2.95
VEEA NASDAQ Head-to-Head Winner
Veea Inc. Common Stock
Services-Computer Integrated Systems Design
$4.78
+6.46% 1D
Market Cap $18.3M
TTM Revenue $491,488
Forward P/E N/M
Beta / 30D Vol -2.32β · 136% Vol
Unified Composite Score
47.7 / 100 HOLD
Tech 40.0 Fund 48.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (67.3% over 20 days), RSI 53
RSI-14: 53.1 · SMA20: $4.73 · SMA50: $4.18

6-Pillar Scorecard Institutional Category Breakdown (TNON 1 – 3 VEEA)

Columns: Metric · TNON · VEEA
1. Valuation Multiples TNON
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 1.5x 62.7x
2. Growth & Scale VEEA
Revenue Growth (YoY) +126.8% +141.6%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $5.3M $491,488
Market Cap $3.8M $18.3M
3. Profitability & Quality VEEA
Gross Margin 66.8% 74.3%
Operating Margin -228.0% -3873.7%
Net Profit Margin -257.9% 0.0%
Return on Equity (ROE) -551.2% 0.0%
4. Balance Sheet & Cash Flow VEEA
Cash Generation (TTM) -$12M EBITDA -$19M
Cash Flow Margin N/A N/A
Net Cash / Leverage $4.0M Net Debt $13M Net Debt (1.67x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markup
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Devices Operator Information Technology Services Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: TNON (2) vs VEEA (6)
Institutional Metric TNON VEEA Criterion Row Edge
Market Capitalization
Scale
$3.8M $18.3M Larger Scale VEEA
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+126.8% +141.6% Higher Growth VEEA
Operating Margin (TTM)
Profitability
-228.0% -3873.7% Higher Margin TNON
Net Profit Margin
Profitability
-257.9% 0.0% Higher Margin VEEA
Return on Equity (ROE)
Capital Efficiency
-551.2% 0.0% Higher ROE VEEA
52-Week Range Position
Momentum
7% ($0–$18) 53% ($0–$9) Stronger Trend VEEA
Beta / 30D Volatility
Risk Regime
-1.54β · 106% Vol -2.32β · 136% Vol Lower Realized Risk TNON
Unified Institutional Score
Composite Signal
41.0 / 100 (SELL) 47.7 / 100 (HOLD) Higher Composite VEEA
Trailing 12M Revenue (USD)
Operating Scale
$5.3M $491,488 FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
66.8% 74.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 1.5x EV/Rev N/M PEG · 62.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$12M EBITDA ($4.0M Net Debt) -$19M ($13M Net Debt (1.67x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon VEEA +64.1 pp
TNON: -50.56% · VEEA: +13.54%
3M Horizon VEEA +3416.82 pp
TNON: -75.5% · VEEA: +3341.32%
6M Horizon VEEA +607.74 pp
TNON: +93.87% · VEEA: +701.61%
1Y Horizon VEEA +723.26 pp
TNON: +13.14% · VEEA: +736.4%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period TNON Revenue VEEA Revenue TNON Op. Margin VEEA Op. Margin Margin Leader
FY2021 $0M N/A -4038.1% N/A TNON
FY2022 $0M N/A -2709.8% N/A TNON
FY2023 $0M $10M -537.1% -114.2% VEEA
FY2024 $0M $0M -420.1% -59309.8% TNON
FY2025 $0M $0M -324.3% -8483.7% TNON

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
TNON UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact TNON Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
VEEA UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact VEEA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
TNON Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $3.8M market capitalization and -228.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
VEEA Moat Profile Cyclical / Execution-Driven Positioning
Information Technology Services Operator
Competes within the Information Technology Services value chain with $18.3M market capitalization and -3873.7% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ TNON vs VEEA Key Questions & Quantitative Answers

As of Nov 16, 2026, Veea Inc. (VEEA) is the stronger overall head-to-head candidate over Tenon Medical, Inc. (TNON) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 3–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). TNON carries a Unified Composite Score of 41.0/100 (SELL) at $1.33 (N/M Forward P/E, -228.0% operating margin), whereas VEEA carries 47.7/100 (HOLD) at $4.78 (N/M Forward P/E, -3873.7% operating margin). Technical & Structure Timing Caution: TNON is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.7); meanwhile VEEA trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 53.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

VEEA leads the Growth & Scale pillar: TNON posts +126.8% YoY revenue growth and +0.0% YoY earnings growth on $5.3M TTM revenue (66.8% gross margin, -228.0% operating margin), compared with VEEA at +141.6% YoY revenue growth and +0.0% YoY earnings growth on $491,488 TTM revenue (74.3% gross margin, -3873.7% operating margin). Across the 5-period historical trajectory (FY2021 to FY2025), TNON cumulative revenue shifted N/A while VEEA shifted N/A. In operating R&D and SG&A reinvestment, TNON deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for VEEA.

TNON screens cheaper on headline valuation multiples. TNON trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 1.5x EV/Revenue (unreported EBITDA margin), whereas VEEA trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 62.7x EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against TNON (-551.2% ROE) versus VEEA (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, TNON carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-1.54β · 106% Vol realized risk). By comparison, VEEA carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-2.32β · 136% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.